bioRxivMicrobiologyPreprint
Decoupling the molecular versatility of aminoglycosides via drug or target modification enables community-wide antiphage defense
L. Kever, Q. Zhang, A. Hardy, P. Westhoff, Y. Yu, J. Frunzke
Abstract
The ongoing arms race between bacteria and phages has forced bacteria to evolve a sophisticated set of antiphage defense mechanisms that constitute the bacterial immune system. In our previous study, we highlighted the antiphage properties of aminoglycoside antibiotics, which are naturally secreted by Streptomyces. Successful inhibition of phage infection was achieved by addition of pure compounds and supernatants from a natural producer strain highlighting the potential for community-wide antiphage defense. However, given the dual functionality of these compounds, neighboring bacterial cells require resistance to the antibacterial activity of aminoglycosides to benefit from the protection they confer against phages. In this study, we demonstrated the successful uncoupling of antiphage and antibacterial properties via different aminoglycoside-resistance mechanisms encompassing drug and target site modifications. Furthermore, we confirmed the antiphage impact of aminoglycosides in a community context by co-culturing phage-susceptible, apramycin-resistant S. venezuelae with the apramycin-producing strain Streptoalloteichus tenebrarius. Given the prevalence of aminoglycoside resistance among natural bacterial isolates that allow functional uncoupling of these compounds, this study highlights the ecological relevance of chemical defense via aminoglycosides at the community level.
- organism: bacteria (other)
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Aminoglycoside antibiotics inhibit phage infection by blocking an early step of the phage infection cycle
L. Kever, A. Hardy, … J. Frunzke·bioRxiv·May 2, 2021
- Phage-induced efflux down-regulation boosts antibiotic efficacy
S. Kraus, U. Lapinska, … S. Pagliara·bioRxiv·Sep 21, 2023
- Temperate phage-antibiotic synergy is widespread, but varies by phage, host, and antibiotic pairing
Rabia Fatima, Alexander P. Hynes·mBioPeer-reviewed·Dec 20, 2024
- Phage-Antibiotic Synergy Is Driven By A Unique Combination Of Antibacterial Mechanism Of Action And Stoichiometry
C. Gu Liu, S. I. Green, … A. W. Maresso·mBioPeer-reviewed·Aug 25, 2020
- Chloramphenicol and gentamicin reduce resistance evolution to phage {Phi}X174 by suppressing a subset of E. coli C LPS mutants
L. Parab, J. Romeyer Dherbey, … F. Bertels·bioRxiv·Aug 28, 2023
- Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: killers and drivers of resistance evolution
Q. J. Leclerc, J. A. Lindsay, G. M. Knight·bioRxiv·Mar 2, 2022